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CHARACTERISTICS OF HIV-INFECTED CHILDREN SEEN IN WESTERN KENYA
W. M. NYANDIKO, A. MWANGI, S. O. AYAYA, E. C. NABAKWE, C. N. TENGE,
P. M. GISORE and R. C. VREEMAN
ABSTRACT
Objectives: To describe the characteristics and outcomes of children registered for care
in a large HIV care programme in Western Kenya.
Design: A retrospective descriptive study.
Setting: USAID-AMPATH HIV clinics in health centres; district and sub-district
hospitals; Moi Teaching and Referral Hospital in Western Kenya.
Subjects: HIV-infected children below age of 15 years seen in a network of 18 clinics
in Western Kenya.
Interventions: Paediatric HIV diagnosis and care including treatment and prevention
of opportunistic infections and provision of combination antiretroviral therapy
(CART).
Main outcome measures: Diagnosis, clinical stage and immune status at enrollment
and follow-up; hospitalisation and death. Descriptive statistical analyses and chi
square tests were performed
Results: Four thousand and seventeen HIV-infected children seen between June 2002
and April 2008. Median age at enrollment was four years (0-14.2 years), 51% girls, 25%
paternal orphans, 10% total orphans and 13% maternal orphans. At enrollment, 25% had
weight-for-Age Z scores (WAZ)> -1 and 21% had WAZ scores < 3. Orphaned children had
worse WAZ scores (p=0.0001). Twenty ﬁve per cent of children were classiﬁed as WHO
clinical stage 3 and 4, 56% were WHO clinical stages 1 and 2 with 19% missing clinical
staging at enrollment. Cough (25%), gastroenteritis (21%), fever (15%), pneumonia (10%)
were the commonest presenting features. Twenty six per cent had been diagnosed with
tuberculosis and only 25% started on cotrimoxazole preventive therapy (CPT). Median
CD4% at enrollment was 16% (0-64%); latest recorded values were 22% (0-64). Sixty four
per cent were on cART (cART+), median age at start was 5.4 (014.4 years).The median
initial CD4% among cART+ was 13 (0-62) compared to 24 (0-64) for those not on ART
(cART-). Median CD4% for cART+ improved to 22% (0-59); whereas cART- was 23% (064) at last appointment. During the period of follow-up, one ﬁfth (19%) of children on
cART were lost to follow-up compared to slightly over one third (37%) for those not on
cART. Thirty four percent were hospitalised; 41% diagnosed with pneumonia. Six per
cent of 4017 were conﬁrmed dead.
Conclusions: HIV -infected children were enrolled in care early in childhood. Orphanhood was prevalent in these children as were gastroenteritis, fever, pneumonia and
advanced immuno-suppression. Orphans were more likely to be severely malnourished.
Only a quarter of children were put on cotrimoxazole preventive therapy. Children
commenced on cART late but responded well to treatment. Loss to follow-up was less
prevalent among those on cART.
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INTRODUCTION
In the last two decades, the Acquired Immune
Deﬁciency Syndrome (AIDS) epidemic that is caused by
the Human Immunodeﬁciency Virus (HIV) has swept
through sub-Saharan Africa with venom. According
to the UNAIDS- www.unaids.org- there are 33.2 million
people living with HIV, 22.5 million of them being
in sub-Saharan Africa and 2.5 million being children
under 15 years. In 2007 alone, there were 420,000
newly infected children worldwide with 330,000
children dying (1). In Kenya, over 1.3 million people
are HIV infected, including over 150,000 children.
The adult prevalence has apparently declined from
a high of 15% in 1998 to a current low of 7.8 % (2).
Stabilised infection levels in this epidemic may be due
to improved prevention but also often result from rising
death rates from AIDS which conceal a continuing
high rate of new infections. There are over 1,100,000
orphans in Kenya due to parental HIV-infection and
death. In 2005 alone, over 140,000 people died from
HIV/AIDS in the country. HIV infection is one of the
top ﬁve causes of mortality in Kenya and has greatly
contributed to the under-ﬁve mortality rate rising from
112 in 1998 to 120 per 1000 in 2004 (3).
HIV-related symptoms and signs are rarely
present at birth, but develop over subsequent
months or years (4). In about a quarter of infected
children, HIV infection progresses rapidly to AIDS
or death in the ﬁrst year (4,5). In the remainder, it
progresses more slowly, with some HIV-infected
children surviving child hood (6). The proportion
of patients who have rapid progression of disease
is higher in children than in adults. In the European
collaborative study, mortality in HIV infected infants
was 15%, and mortality by the age of ﬁve years was
28%, ﬁndings similar to those in the Italian study (6).
According to the European experience, the annual
rate of progression to AIDS decreases after the ﬁrst
year to approximately 6-8%, as does the mortality
rate (5,6).
The morbidities of HIV-infected children may
vary by geographical location. HIV -infected children
in Africa frequently suffer from pneumonia, diarrhoea,
bacteremia, failure to thrive and lymphadenopathy.
In Cote d’Ivoire, among 338 consecutively admitted
HIV-infected children, 26% had respiratory infections
and 26% had malnutrition (7). In South Africa, among
48 children with vertically transmitted HIV infection
followed for 26 months, 78% had diarrhoea, 76%
pneumonia and 70% lymphadenopathy. Twenty ﬁve
per cent died at a mean age of 10 months (but up
to 48 months); the top four diagnoses at the time of
death being dirrhoea, pneumonia, failure to thrive
(FTT) and severe oral thrush (8). Mortality is also
consistently higher among hospitalised children who
are HIV-positive than those who are HIV-negative.
The mortality rate among 354 HIV positive children
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aged between six months and ﬁve years hospitalised
in Zambia was 19%, a rate signiﬁcantly higher than
the mortality rate of 9% among 912 hospitalised,
HIV-negative children (9).
The effect of combination antiretroviral therapy
(cART) on the disease progression and outcomes of
HIV-infected children in Africa has not been wellstudied, in part because few children are on cART.
At the end of 2006, the WHO estimated that 115,000
children had access to HIV treatment a coverage rate
of about 15%. In Kenya, only about 90,000 patients
are on cART, out of an eligible population of over
750,000, with only 13,000 being children (10). Thus,
data on African children’s cART outcomes are just
beginning to accumulate. In pooled data studying
392 children on cART in resource-limited settings
including Africa, the median gain in CD4% was 8.2 at
6 months (n=48, IQR: 4.8-12.6) and 10.2 at 12 months
(n=12, IQR: 6.6-16.3). The median Weight-for-Age Z
score (WAZ) gain was +0.89 at 6 months and +0.92
at 12 months. Mortality over time was 7.8% (11). In a
study in Western Kenya, children on cART had a good
response irrespective of their orphan status, with the
only remarkable ﬁnding being a lag in weight gain
among the orphans on cART (12).
Moi University School of Medicine, in
collaboration with Moi Teaching and Referral
Hospital (MTRH), has recognised the pivotal role their
institutions must play in Kenya’s overall response to
the threat presented by HIV-AIDS pandemic. These
institutions, in partnership with Indiana University
School of Medicine and USAID, established the
USAID-Academic Model for the Prevention and
Treatment of HIV-AIDS, now known as the USAIDAcademic Model Providing Access to Healthcare
(USAID-AMPATH) (13). USAID-AMPATH embraces
excellent patient care, education of patients, medical
and nursing students, research and rural health centre
participation. As Kenya implements anti-retroviral
therapy in persons infected with the HIV virus,
USAID-AMP A TH has provided care for over 89,000
patients, including over 16,000 children. The USAIDAMPATH cohort of patients provides an optimal
setting in which to describe HIV-related outcomes
for Paedriatic patients in East Africa.
We need to examine the demographic and
clinical characteristics, morbidities and outcomes
for HIV-infected children in East Africa. Such studies
will inform strategic protocols and improve the
efﬁcacy of HIV care and management. Describing
HIV-related characteristics and outcomes for our
cohort of HIV -infected children will not only
beneﬁt the thousands of children followed by the
USAID-AMPATH programme, but will also provide
important information for Kenya, the East African
region, and beyond.
The main objective of the study was to describe the
demographic and clinical characteristics; diagnoses;
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treatment and follow-up outcomes among a cohort
of HIV-infected children in care at a large HIV care
programme in Western Kenya.
MATERIALS AND METHODS
Study design: This was a retrospective descriptive
study. We used prospectively collected de-identiﬁed
data from the computerised medical records of HIV
-infected paedriatic patients treated in the USAIDAMPATH clinical care system in Western Kenya. The
study was approved by the Institutional Research
and Ethics Committee of the Moi University School
of Medicine and Moi Teaching and Referral Hospital
(Eldoret, Kenya) and the Institutional Review
Board of the Indiana University School of Medicine
(Indianapolis, IN).
Study site: USAID-AMPATH operates an urban
referral clinic at the Moi Teaching and Referral
Hospital (MTRH) in Eldoret, Kenya, a national
tertiary referral hospital serving a catchments area
of approximately 13 million people. Comprehensive
HIV care services for children are also provided at 17
outlying outpatient clinics (Mosoriot, Turbo, Burnt
Forest, Amukura, Naitiri, Chulaimbo, Webuye,
Teso, Kitale, Kapenguria, Mt. Elgon, Hen, Kabarnet,
Busia, Port Victoria, Uasin-Gishu and Khuyangu),
located within district hospitals and health centres
throughout Western Kenya. HIV care is provided by
paeditricians, medical ofﬁcers and clinical ofﬁcers
trained and mentored within AMPATH.
Study population: Eligible patients included any child
seen in any of 18 USAID-AMPATH clinics between
June 2002 and April 2008 who was HIV-infected and
less than 15 years of age.
Clinical procedures: Throughout the period of the
study, clinicians followed detailed, locally developed
protocols consistent with World Health Organisation
guidelines. HIV infection was documented by DNAPCR (Amplicor, Roche, Basel, Switzerland) for children
<18 months and by two parallel HIV rapid ELISA tests
using Determine and Unigold kits for children >18
months. cART was initiated for any children <6 years of
age with a CD4 cell percentage of <15%, for any child
>6 years of age with a CD4 count <200 cells/mm3, and
for all children with WHO clinical stages 3 or 4 or CDC
stage C disease. The standard initial cART regimens
used were zidovudine/lamivudine/nevirapine for
those weighing <10kg or stavudinel/amivudine/
nevirapine for those weighing >10 kg. All patients
were started on cotrimoxazole preventive therapy if
below the age of six years. Those above six years of
age with a CD4 % of less than 25% and those with
WHO stages 3 or 4 were also put on cotrimoxazole.
Children started on cART were seen two weeks
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after initiation of therapy, and then every month
thereafter. During these visits, patients undergo
clinical assessments, including assessment of family
and social characteristics, nutritional status, the
degree of immuno-suppression, current or chronic
infections, dietary intake, drug/treatment history
and adherence history. Laboratory investigations
included routine assessment of CD4% every six
months and investigations to evaluate haemoglobin
level, liver, kidney functions every three months.
Tests to evaluate for toxicities were performed as
necessary. Loss to follow-up was deﬁned as missing
clinic appointment for more than six months for those
not on cART and more than three months for those
on cART. An orphan was deﬁned as a child who had
lost either both or one of the parents. Nutritional
status was deﬁned using the following categories:
a weight-for-age Z score (WAZ) of >1 indicated
normal nutritional status, a WAZ score of -1 to -2
indicated mild malnutrition, a WAZ score of -2 to -3
indicated moderate malnutrition, and a WAZ score
of <3 indicated severe malnutrition.
Data collection and management: Clinicians completed
standard initial and return encounter forms at all
USAID-AMPATH clinic visits for the children (http://
amrs.iu-Kenya.org/download/forms). The initial encounter
form included standard demographic; birth and
prevention of mother to child transmission prophylaxis
history; dietary intake; social; physical; examination;
laboratory data and medications provided including
antiretroviral drugs and opportunistic infection
prophylaxis. At each subsequent clinical encounter,
follow-up data were collected on inter-current
symptoms, medication adherence, new diagnoses,
laboratory data, and modiﬁcations in medication
regimens. Dedicated data entry clerks entered this
information into the ambulatory USAID-AMPATH
Medical Record System with data entry validated by
random review of 10% of the data entered. The medical
records system was MS Access-based (Microsoft
Corporation, Redmond, WA) until 2006, and currently
uses MySQL based database.
Statistical methods: Descriptive statistics such as mean,
standard deviation, median and range were used for
the continuous variables while frequency listings were
used for categorical variables. The chi-square test was
used to assess any association between a categorical
variable and each of the independent variables, where
the cell count were below 10 the Fishers’ exact test
was used in 2 by 2 tables. Plots were used to explore
the trends of the CD4% of children over time, and this
was done both overall and by orphan status, since
orphan status was hypothesized to have an effect
on the trend. All statistical analyses were performed
using SAS Institute version 9.1. A p-value of less than
0.05 was considered signiﬁcant in all analyses.
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RESULTS
Data were available for 4017 HIV-infected children
who were seen in the USAID-AMPATH outpatient
HIV clinics from June 2002 to April 2008. The majority
of patients were enrolled at the outpatient HIV clinic
at the urban outpatient clinic of Moi Teaching and
Referral Hospital (33%) with the remaining patients
enrolled at district hospitals and rural health centres
(Table 1). The median age at enrollment was 4.5
years (range: 0 years-14.2 years), with the median
duration of follow-up being 15 months (range: 0.0074 months). At enrollment, 10% of the children were
less than ﬁve months old, almost 50% were between
ﬁve months and ﬁve years old, and 40 % were older
than ﬁve years. About half of the children were girls
(51%). A total of 59% were orphaned at enrollment:
25% being paternal orphans, 13% maternal and 11%
total orphans. The predominant ethnic group of the
children was Luhya (32%) with the rest being Kalenjin
(27%), Luo (20%), Kikuyu (10%) and others. At the
time of cART initiation, more than half of the children
on cART were brought to the clinic by their mothers
(52%), 14% by their grandparents, 11.5% by an auntie
or uncle and only 8% by their fathers. The majority of
children had less than two siblings (53%), with only
14% having ﬁve or more siblings.
Table 1
Demographic characteristics of children
No.
(%)
Gender
Male
1959
48.78
Female
2057
51.22
Clinic
MTRH
1307
32.54
MRHC
343
8.54
Turbo
236
5.88
Burnt Forest
219
5.45
Chulaimbo
353
8.79
Webuye
223
5.55
Kitale
345
8.59
Busia
158
3.93
Distant clinics
833
20.74
Orphaned status
Paternal
995
24.77
Maternal
536
13.34
Total
428
10.65
Non orphaned
1145
22.73
Unknown
913
28.50
Conﬁrmed dead?
Yes
224
5.58
No
3793
94.42

Ever On ARVs?
Yes
No
Child attended school
Yes
No
Non-applicable
Missing
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2576
1441

64.13
35.87

882
247
1009

41.25
11.55
47.19

1879

Clinical status at presentation: The majority (78%) of the
children over nine months of age had completed their
immunisations as deﬁned by the Kenya Expanded
Programme of Immunization (KEPI) schedule. More
than a quarter (25%) of the patients had normal WAZ
scores at enrollment, another one quarter (26%) had
mild malnutrition, 26% had moderate malnutrition,
and 22% were severely malnourished (Table 2).
Table 2
Anthropometric measures (n=4017)
No.
(%)
Age at enrolment in categories
<5 months
410
10.60
5 months- 1 year
328
8.48
1 to 5 years
1549
40.04
5-12 years
1462
37.79
12-15 years
120
3.10
Age at start of ART in categories
<1 year
146
5.68
1 to 5 years
1050
40.87
5-12 years
1248
48.58
12-15 years
125
4.87
WAZ score closest to enrolment (n=3724)
< 3
816
21.91
-3 to -2
982
26.37
2 to -1
990
26.58
> 1
936
25.13
Missing
170
WAZ score at last
appointment (n=3765)
< 3
535
14.21
-3 to -2
843
22.39
-2 to -1
1220
32.40
> 1
1167
31.00
Missing
129
There was a statistically signiﬁcant difference between
the nutritional status of non-orphaned children
compared to the orphaned children at enrollment
(p=0.0001), with orphaned children having more
malnutrition (Table 3).
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Table 3
Comparing nutritional status by orphan status
Variable

Orphan
No. (%)
(n=941)
192 20.40
291 30.92
278 29.54
180 19.13
(n=948)
109 11.50
348 26.90
468 35.97
296 25.63

WAZ score at ﬁrst appointment
< 3
-3 to-2
-2 to -1
> 1
WAZ score at last appointment
< 3
-3 to-2
-2 to-l
> 1

More than two thirds of the children were either
asymptomatic or mildly symptomatic at enrollment
(56%), with only 26% being in WHO stages 3 and 18%
in WHO stage 4 (Table 4). The most common presenting
symptoms and diagnoses at enrollment were rash/
dermatitis (32%), cough (25%), gastroenteritis (21%),
fever (15%), pneumonia (10%), otitis media (8%),
oral thrush (8%), failure to thrive (6%), and delayed
milestones (2.5%). Slightly more than one quarter
had been diagnosed with tuberculosis (TB) at some
time point either before or after enrollment. Only
one quarter (24%) had ever been on cotrimoxazole
for pneumocystis carinii prophylaxis (Table 4).
Table 4
Clinical diagnoses and signs and symptoms (n=4017)
No.
WHO staging at
enrolment (n=3844)
Stage 1
Stage 2
Stage 3
Stage 4
Missing
WHO staging at last
appointment (n=3844)
Stage 1
Stage 2
Stage 3
Stage 4
Missing
Develop TB? (n=4017)
Yes
No

(%)

957
1193
998
696
173

24.90
31.04
25.96
18.11

695
895
964
1290
173

18.08
23.28
25.08
33.56

1083
2934

26.96
73.04

Non-orphan
No. (%)
(n=1755)
421 23.99
417 23.76
434 24.73
483 27.52
(n=1722)
305 17.21
376 21.22
523 29.51
568 32.05

Develop TB? (n=1083)
At enrolment
215
After enrolment
868
Develop TB? (n=1083)
After ARV
174
Before ARV
559
Never on ARV
350
Hospitalisation
Yes
778
On septrin
978
Over 9 months (n=3702)
Completed immunisation

P-value

<0.0001

<0.0001

19.85
80.15
16.07
51.62
32.32
19.38
24
2898

Table 5
Laboratory tests
CD4% closest to enrolment (n=2975)
Mean (sd)
17.49 (10.96)
Median (range)
16.00 (0,64)
CD4% at last appointment (n=3273)
Mean (sd)
22.08 (10.41)
Median (range)
22.00 (0.64)
CD4 count closest to enrollment (n=3275)
Mean (sd)
639.56 (587.58)
Median (range)
484 (0.4337)
CD4 count at last appointment (n=3317)
Mean (sd)
815 (588)
Median (range)
703(0.4262)
WBC at closest to enrolment (n=984)
Mean (sd)
7619 (4247)
Median (range)
6776 (102,30000)
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Hgb at closest to enrolment (n=2851)
Mean (sd)
14.55 (226)
Median (range)
10.40
(0.10.70,12100)
ALC at closest to enrolment (n=578)
Mean (sd)
3829.58
(2898.35)
Median (range)
3310(1.58,4600)
Clinical and immunologic course: By the time of the
last appointment in the database, there was an
improvement in nutritional status for most children
(Table 3). Orphaned children continued to be
more likely to be malnourished (were time, with
signiﬁcantly lower WAZ scores at the most recent
assessment of nutritional status (p=0.0001).
Of the 1043 diagnosed with TB, the majority
(80%) were diagnosed after enrollment. The majority
of the children who developed TB were diagnosed
with TB prior to initiation of cART (52%) compared
to 16% who developed TB while on cART.
The median CD4 count and percentages closest to
enrollment were 484 (range: 1-4337) and 16% (range:
0-64%) respectively (Table 6).
The median CD4 count and percentage increased
slightly when examining the most recent clinical
measurement, 703 (range 1-4262) and 22% (range
0-64) respectively (Figures 1 and 2). Orphan status
did not affect these trends. (Figures 3 and 4).
Figure 1
CD4 percent proﬁle for children on ART
35

CD4 per cent

30
25
20
15
10

-12m -6m
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0m 1m
6m 12m 18m >18m
Time to start of ARV in months
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Figure 2
CD4 percent proﬁle for children not on ART
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30m

36m >36m

Time in months from enrollment

Anti-retroviral therapy and opportunistic infections
prophylaxis status: About two thirds (64%) of all HIV
-infected children were on cART during the period
of the study. The median age at start of the cART
was 5.3 years (range: 0-14.4 years). Only 6% of the
children on ART were below one year of age, 41%
between one and ﬁve years, and more than half (52%)
above ﬁve years.
The children started on cART had a median
CD4 count and percent of 375 (range 1-4202) and
13% (range 0-62%) respectively closest to enrollment.
Those not on ART had higher counts of 814 (range
0-4331) and 24% (range 0-64%) respectively closest
to enrollment (Table 6). The median CD4 counts
increased at the last appointment for those on cART
to 671 (range 0-4262) and 22% (range 059). However,
these values declined slightly in those not on cART
to 787 (range 0-3940) and 23 (range 0-64) respectively.
(Figures l and 2) Among those on cART, orphaned
children tended to have a lower latest recorded CD
4% compared to the non-orphaned (Figure 3). The
trends of CD4 percent did not vary much between
the different age categories (Figure 5).
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Figure 3
Median CD4 percent for those on ART by orphan status
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Figure 4
Median CD4 percent for those not on ART by orphan
status
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Figure 5
Median CD4 percent for children on cART with age
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10
< 6 months
50
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> 12 years
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Unknown
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Orphans
Unknown

1 – 5 years
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Table 6
CD4 by ARV status

CD4% closest to enrolment
Mean (sd)
Median( range)
CD4% at last appointment
Mean (sd)
Median (range)
CD4 count closest to enrolment
Mean (sd)
Median( range)
CD4 count at last appointment
Mean (sd)
Median(range)

Ever on ARV
(n=2107)
14.66 (9.84)
13.00 (0.62)
(n=2380)
21.66 (10.64)
22 (0,59.00)
(n=2380)
505.54 (475.44)
375 (1.4202)
(n=2406)
768.77 (558.79)
671.5 (1.4262)

Follow-up and admission characteristics: Aquarter (26%) of
the children were lost to follow-up during the duration
of follow-up, with 19% of those on cART being lost to
follow-up compared to slightly over one third (37%)
for those not on cART. Only 6% were conﬁrmed dead
after enrollment.
About one ﬁfth of the children (19%) were ever
admitted after enrollment to various hospitals in
the vicinity of AMPATH clinics during the study
period. Ninety one patients were admitted to the
biggest and referral facility in the programme, MTRH.
Documentation for admission to other peripheral
health facilities was incomplete and was not included.
The most common reasons for admission at MTRH
were pneumonia (n=60), malaria (n=22), pulmonary
tuberculosis (n=14), meningitis (n=9), dehydration (n=9)
and malnutrition (n=5). Of those admitted in MTRH,
24 died and the rest were discharged. One third (32%)
of all those admitted had ever been on cART.
DISCUSSION
In this retrospective study, we describe the characteristics
of a large cohort of HIV infected children in sub-Saharan
Africa. The most common presenting symptoms and
diagnoses in this cohort compares well with other
African cohorts (8,9). Skin rash; chronic or recurrent
cough probably associated with tuberculosis, lymphoid
interstitial pneumonitis and upper respiratory tract
infections; gastroenteritis and oral thrash formed some
of the common presenting features. Interestingly, only
26% of the children seen in this cohort were diagnosed
with tuberculosis before and after enrollment. This is
low compared to estimated rates of TB in other children
populations in Africa (9). However, this may be an
indication that we are under-diagnosing tuberculosis
in children, a well recognised challenge in resource
limited settings where diagnostic capabilities are still

Not on ARV
(n=868)
24.38 (10.48)
24 (0.64)
(n=893)
23.20 (9.70)
23.0 (0.64)
(n=900)
992.93 (698.12)
814 (0.4331)
(n=911)
935.01 (646.57)
787 (0.3940)

limited and criteria for diagnosing TB still not well
validated in the background of HIV infection (14).
A majority of the children presented at a relatively
good WHO clinical stage, emphasizing the fact that
our local population may be heeding the call by
health personnel, community mobilisers and media
for the affected families to present early for testing
and care. In addition, this means that the children in
our cohort are identiﬁed early for care. In contrast
to early literature describing late presentation of
African children (7-9), we are only seeing about 40%
in WHO stages 3 and 4 at presentation. The rapid
progression of HIV in children may be explained by
the level of maturity of the immune system at the
time of HIV acquisition. Infants with HIV are also
exposed to primary infections and opportunistic
organisms which is different from the reactivation
of such infections that occurs in adults.
Early enrollment to paedriatic HIV care will
translate to early treatment of opportunistic infections
and early initiation on ART and therefore better survival
(15,16). We however noted a low uptake of cotrimoxazole
preventive therapy. This may be explained by the fact
that almost half of the children have a good clinical and
immunological status and therefore did not qualify for
CPT. We have however also noted a lack of compliance to
the protocols by some clinicians. This is being addressed
by retraining and mentoring of the clinicians. We are also
in the process of introducing electronically generated
reminders to clinicians to initiate all eligible children
on CPT. This will deﬁnitely help reduce the morbidity
and mortality from common conditions prevalent in
this population of children as has been described in
Zambian children (17).
In this cohort, the majority of children receiving
care in the comprehensive clinics in Western Kenya
are the under-ﬁves, indicating the increased ability of
prevention of mother to child service and other entry
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points in identifying the infants early and starting
them on co-trimoxazole and follow-up. This might
explain the relatively low crude mortality in this cohort.
Early infant diagnosis is known to prevent morbidity
and mortality as has been described in studies in
South Africa and Uganda (15,19). In the AMPATH
programme, the pMTCT programme was ramped
up in 2002-2004 leading to early clinic attendance in
index children and their siblings (13). We therefore
demonstrate that it is possible to diagnose these
children early despite the often reported delays in early
diagnosis in resource limited settings. The use of all
points of entry including ante natal clinic, outpatient
clinics, TB clinics and wards for paedriatic diagnosis
is not reported in many care settings. In Uganda and
South Africa (18,19) efforts in ANC and outpatient
clinics reported improvements in the rate of early
diagnosis comparable to what we ﬁnd in this study.
More resources and targets need and can be set aside
to achieve this lifesaving objective in programmes in
low income countries.
The immunologic status of the children was
also relatively good unlike the ﬁndings of the adult
population in the same care and in other studies
in Africa (20). Immunologic status was lower at
enrollment for those started on ART. The median CD4
count and percentage was lower when we looked at
the most recent counts for those not on ART and, as
expected, was higher in those on ART in recent counts.
This suggests the success of ART in this cohort, and
matches the previous analyses of an earlier cohort
(12) and other African cohorts (20). The trends of CD4
percent in different age categories did not vary much
(Figure 5). One would have expected a more rapid
decline for those below one year of age. This is perhaps
explained by the consistent follow-up, prevention and
treatment of opportunistic diseases in these children
thus maintaining a relatively good CD4 percent.
The nutritional status of the children was
relatively good at enrollment. It was signiﬁcantly
lower at enrollment for those who subsequently began
ART. The status was also signiﬁcantly lower among
orphaned children compared with the non-orphaned,
a feature that has been noted in an earlier cohort in
the same programme on ART (12). In that study, the
orphaned children seemed to lag in improvement of
their nutritional status compared to the non-orphaned
after 100 weeks of follow-up. In the current analysis,
nutritional status improved in both groups albeit a
small lag of the latest values for the orphaned on cART,
which may reﬂect the impact of nutritional support
for families that is now provided in this programme
(13). In this nutritional programme, children with
malnutrition or food insecurity as assessed by the
nurses or nutritional assistants at each visit are initiated
on food rations that include pulses and oil (provided
by World Food Program) and vegetables (provided
from USAID-AMPATH demonstration farms) until
there is improvement in the nutritional status and
food security situation. This is an important ﬁnding
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that requires more investigation on the effect of good
nutrition in delaying initiation of ART in children.
The median haemoglobin level at enrollment
in this cohort was relatively high at 10gm/dl. This
is a reassuring ﬁnding in such a young population,
particularly since a signiﬁcant number of the children
are using zidovidune, a potential bone marrow
suppressant. In addition, the median white cell count
and absolute lymphocyte counts were relatively high,
though lower in the group that was started on ART.
There were no signiﬁcant differences in the absolute
lymphocyte counts from different geographical and
therefore ethnic sites, as contrast to ﬁndings in the
adult population in the same programme (unpublished
data, under review at EAMJ).
Less than one quarter of the patients were ever
admitted to hospital. The most common reasons for
admission of the cohort seen at MTRH were pneumonia,
gastroenteritis, malaria, pulmonary tuberculosis and
meningitis. These ﬁndings are similar to those in other
African countries (8,9,20,21). Mortality was low in this
cohort, reﬂecting relatively good care in a resourceconstrained setting. However, there is a high loss to
follow-up, and it is difﬁcult to say whether some of
these might be unreported deaths. The children on
cART are less likely to be lost to follow-up and this
is probably evidence of sustained education, support
and follow-up that is accorded to children on cART
by the caregivers and care providers. The difﬁculty
associated with inability to trace our patients is a
common feature in Africa where homes do not have
well deﬁned location. This is however being addressed
in an outreach programme within USAID-AMPATH,
and we hope to have less loss to follow-up and better
data on mortality form this cohort in the future.
The majority are brought to the clinic by their
mothers as is cultural in African countries. However,
the grandparents, aunts and uncles also playa key role
in bringing HIV infected children for care in those that
are orphaned. This has been described in other African
cohorts where the extended families have been able to
lessen the burden that the orphans would otherwise
face (22). More than two thirds of the children seen in
this cohort are orphaned, with more than 10% having
both parents’ dead. This is consistent with the high
prevalence of orphan-hood within Kenya. Other
studies in African countries report higher rates of
orphan-hood (22). Within this population, more
children have lost their fathers than their mothers.
This may reﬂect that women seek healthcare earlier
than men as reported in WHO bulletins. In addition,
the higher prevalence of paternal orphans may
spring from earlier HIV infection, progression, and
death among men compared to women (22).
This cohort describes ﬁndings in children that
have access to a comprehensive package including
nutritional support, micro-enterprise programmes
to families to facilitate income generation, and free
drugs, including ART and drugs for opportunistic
infections. It may therefore not be representative,
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at least in terms of disease progression in other
resource-limited settings, including those run by
the Kenyan Ministry of Health. In addition, the high
rate of LTFU may affect the ﬁndings of this study.
In conclusion, we note that HIV -infected children
were enrolled in care early in childhood. Orphanhood was prevalent in these children as were
gastroenteritis, fever, pneumonia and advanced
immuno-suppression. Orphans were more likely to
be severely malnourished. Only a quarter of children
were put on contimoxazole preventive therapy.
Children commenced on cART late but responded to
treatment well. Loss to follow-up was less prevalent
among those on cART.
We recommend long term follow-up of children
in this and other similar settings to determine the
natural progression for those on ART and those not
on ART. The nutritional status of orphaned children
needs to be assessed more aggressively and managed
early. Efforts to increase uptake of cotrimoxazole
preventive therapy and decrease the loss to followup need to be intensiﬁed.
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